Simplify Propel Opportunities ETF (SURI)
Data kepemilikan belum tersedia untuk dana ini.
SURI Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Performa per 30 Sep. 2026
| Periode | Imbal hasil harga | Imbal hasil total |
|---|---|---|
| 1M | ▼ -13,14% | ▼ -9,99% |
| 3M | · | · |
| 6M | · | · |
| YTD | · | · |
| 1Y | · | · |
| 3Y | · | · |
| 5Y | · | · |
| Maks | ▼ -9,56% | ▼ -6,27% |
Total pengembalian mengasumsikan dividen diinvestasikan kembali. Pengembalian tidak dibandingkan dengan indeks. * Rasio Sharpe dihitung dengan suku bunga bebas risiko 0%.
Aliran dana (dilaporkan SEC)
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Komposisi Penuh 39 saham
| Nama | CUSIP | Nilai | % | Saldo | Kategori | Negara |
|---|---|---|---|---|---|---|
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797VM6 | $59.3M | 76,77 | 60.000.000 | DBT | US |
| PLAINS GP HOLDINGS LP | 72651A207 | $30.9M | 39,97 | 1.272.360 | EC | US |
| ACHIEVE LIFE SCIENCES INC | 004468500 | $9.4M | 12,11 | 1.432.105 | EC | US |
| MILESTONE PHARMACEUTICALS INC | 59935V107 | $4.5M | 5,81 | 3.349.379 | EC | CA |
| ACHIEVE LIFE SCIENCES INC | 004468187 | $3.4M | 4,42 | 966.667 | EC | US |
| DELCATH SYSTEMS INC | 24661P807 | $3.3M | 4,26 | 261.126 | EC | US |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | $2.7M | 3,50 | 249.267 | EC | US |
| CORCEPT THERAPEUTICS INC | 218352102 | $2.3M | 2,98 | 26.434 | EC | US |
| ABEONA THERAPEUTICS INC | 00289Y206 | $2.1M | 2,76 | 345.416 | EC | US |
| CELLDEX THERAPEUTICS INC | 15117B202 | $2.0M | 2,56 | 53.134 | EC | US |
| KYVERNA THERAPEUTICS INC | 501976104 | $1.6M | 2,11 | 182.603 | EC | US |
| COMPASS PATHWAYS PLC | 20451W101 | $1.6M | 2,09 | 114.281 | EC | GB |
| LEONABIO INC | 04746L203 | $1.4M | 1,78 | 149.279 | EC | US |
| INVENTIVA SA | 46124U107 | $1.2M | 1,53 | 313.483 | EC | FR |
| AQUESTIVE THERAPEUTICS INC | 03843E104 | $1.2M | 1,50 | 278.723 | EC | US |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | $983K | 1,27 | 101.355 | EC | US |
| ZEVRA THERAPEUTICS INC | 488445206 | $966K | 1,25 | 67.372 | EC | US |
| ORCHESTRA BIOMED HOLDINGS INC | 68572M106 | $947K | 1,23 | 219.387 | EC | US |
| PALISADE BIO INC | 696389402 | $942K | 1,22 | 450.543 | EC | US |
| TELESAT CANADA / TELESAT LLC | 87952VAR7 | $895K | 1,16 | 1.000.000 | DBT | CA |
| OCULAR THERAPEUTIX INC | 67576A100 | $796K | 1,03 | 81.051 | EC | US |
| ACHIEVE LIFE SCIEN RTS | · | $748K | 0,97 | 247.593 | EC | US |
| EYEPOINT INC | 30233G209 | $649K | 0,84 | 45.409 | EC | US |
| IMMUNIC INC | 4525EP200 | $472K | 0,61 | 30.725 | EC | US |
| UPSTREAM BIO INC | 91678A107 | $430K | 0,56 | 62.113 | EC | US |
| Akero Therapeutics Inc | 009CVR044 | $427K | 0,55 | 145.609 | EC | US |
| SAB BIOTHERAPEUTICS INC | 78397T202 | $409K | 0,53 | 104.849 | EC | US |
| OVID THERAPEUTICS INC | 690469101 | $260K | 0,34 | 96.817 | EC | US |
| ALTIMMUNE INC | · | $3K | 0,00 | 79.075 | EC | US |
| CHINOOK THERAPEUTICS INC | 169CVR016 | $2K | 0,00 | 25.000 | EC | US |
| Eiger BioPharmaceuticals Inc | 28249U204 | $900 | 0,00 | 90.000 | EC | US |
| MILESTONE PHARMACE WTS | · | $2 | 0,00 | 1.842.974 | EC | US |
| JASPER THERAPEUTIC WTS | · | $1 | 0,00 | 609.053 | EC | US |
| WTS - TENAYA THERAPEUTICS | · | $1 | 0,00 | 560.000 | EC | US |
| QUOIN PHARMACEUTIC WTS | · | $0 | 0,00 | 34.895 | EC | US |
| QUOIN PHARMACEUTIC WTS | · | $0 | 0,00 | 34.895 | EC | US |
| QUOIN PHARMACEUTIC WTS | · | $0 | 0,00 | 34.895 | EC | US |
| QUOIN PHARMACEUTIC WTS | · | $0 | 0,00 | 34.895 | EC | US |
| MORGAN STANLEY & CO. LLC | · | -$58.1M | -75,22 | -58.112.171 | RA | US |
Dividen 15 pembayaran
| Tanggal ex-dividen | Jumlah / saham |
|---|---|
| 25 Sep. 2026 | $0,6800 |
| 25 Juni 2026 | $0,6800 |
| 26 Maret 2026 | $0,6800 |
| 23 Des. 2025 | $0,6800 |
| 25 Sep. 2025 | $0,6800 |
| 25 Juni 2025 | $0,6800 |
| 26 Maret 2025 | $0,6800 |
| 23 Des. 2024 | $0,6800 |
| 25 Sep. 2024 | $0,6800 |
| 25 Juni 2024 | $1,2500 |
| 25 Maret 2024 | $0,6800 |
| 26 Des. 2023 | $0,6800 |
| 27 Sep. 2023 | $0,6800 |
| 27 Juni 2023 | $0,6800 |
| 27 Maret 2023 | $1,0000 |
Pemilik institusional (13F) 1 pengaju
Institusi yang melaporkan kepemilikan ETF ini dalam Formulir SEC 13F triwulanan mereka. Hanya posisi long; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Institusi | Nilai | % dari 13F yang dilacak | Saham | Tipe | Per tanggal |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | $221.164 | 100,00% | 12.359 | Saham | 30 Juni 2026 |